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Abstract
Background: The serine/threonine protein kinase C (PKC) theta has been firmly implicated in T cell-mediated
immunity. Because its role in macrophages has remained undefined, we employed PKCtheta-deficient (PKCtheta−/−)
mice in order to investigate if PKCtheta plays a role in macrophage-mediated immune responses during bacterial
infections.
Results: Our results demonstrate that PKCtheta plays an important role in host defense against the Gram-negative,
intracellular bacterium Salmonella typhimurium, as reflected both by markedly decreased survival and a significantly
enhanced number of bacteria in spleen and liver of PKCtheta−/− mice, when compared to wild-type mice. Of note, albeit
macrophages do not express detectable PKCtheta, PKCtheta mRNA expression was found to be profoundly upregulated
during the first hours of lipopolysaccharide (LPS)/interferon-gamma (IFNgamma)-, but not IL-4-mediated cell polarization
conditions in vitro. Mechanistically, despite expressing normal levels of classically activated macrophage (CAM) markers,
PKCtheta-deficient CAMs expressed significantly higher levels of the anti-inflammatory cytokine IL-10 in vivo and in vitro
when challenged with S. typhimurium or LPS/IFNgamma. Neutralization of IL-10 recovered immune control to S.
typhimurium infection in PKCtheta-deficient macrophages.
Conclusions: Taken together, our data provide genetic evidence that PKCtheta promotes a potent pro-inflammatory
CAM phenotype that is instrumental to mounting protective anti-bacterial immunity. Mechanistically, PKCtheta exerts a
host-protective role against S. typhimurium infection, and acts as an essential link between TLR4/IFNgammaR signaling
and selective suppression of the anti-inflammatory cytokine IL-10 at the onset of CAM differentiation in the course of a
bacterial infection.
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Background
Macrophages (Mφ) play important roles in inflammatory
and infectious diseases. Mφ polarization phenotypes, how-
ever, are heterogeneous and profoundly affected by local
factors within the microenvironment. Microbial stimuli
such as lipopolysaccharide (LPS), interleukin-1beta (IL-
1beta), and cytokines secreted by Th1 lymphocytes, such as
interferon-gamma (IFNgamma) induce a “classic” Mφ
phenotype (CAM). Activated CAMs are pro-inflammatory
Mφ and produce high levels of pro-inflammatory cytokines
like tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-
1beta, IL-23 and IL-12. CAMs are essential components of
anti-microbial host defense and further characterized by
production of reactive oxygen species and reactive nitrogen
species during the promotion of a Th1-type driven response
[1–3]. Because these pro-inflammatory CAMs may cause
extensive tissue damage, their activation is tightly con-
trolled. Indeed, CAMs are established to be involved in
autoimmune diseases such as systemic lupus erythematosus
and rheumatoid arthritis [4]. In contrast, Th2 lymphocyte
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cytokines such as IL-4 and IL-13 promote the alternatively
activated Mφ phenotype (AAM) that dampens the inflam-
matory state by producing anti-inflammatory mediators
such as IL-10. Signature genes for AAMs are Arginase-1,
chitinase-like molecules YM1 and YM2, and resistin-like
molecule Fizz-1 (Relm-alpha, Retnla) [5, 6]. AAMs, in par-
ticular, produce high amounts of the anti-inflammatory
cytokines IL-10 and Tumor growth factor beta (TGFβ),
thereby inhibiting pro-inflammatory immune responses.
Thus, AAMs are involved in tissue remodelling [7] and
tumor progression [8].
Protein kinase C (PKC) isotypes are members of the
serine/threonine protein kinase subfamily, and play an
important role in the regulation of a variety of cell func-
tions. PKCtheta (PKCtheta), a member of the nPKC sub-
family, is predominantly expressed in T cells. Most of
our current knowledge about PKCtheta therefore arises
from studies performed in T cells. We and others could
show that PKCtheta plays a critical role in the NF-
kappaB, AP-1, and Ca2+/NFAT pathways to activate e.g.
the interleukin-2 cytokine promoter [9, 10]. Madaro et
al. demonstrated that PKCtheta has an immune cell in-
trinsic role in muscle tissue repair during muscular dys-
trophy inflammation [11]. More recently, Ma et al.
reported a role for PKCtheta in cholesterol metabolism
in human Mφ [12]. Because different PKCs, namely
PKCalpha, PKCbeta, PKCdelta and PKCzeta, have been
shown to have a critical role in Mφ antimicrobial im-
mune responses [13–16], we investigated the functional
role of PKCtheta in Mφ biology. Here we demonstrate
that the genetic ablation of PKCtheta expression in mice
leads to exacerbation of disease progression and early
death in Salmonella (S.) typhimurium infection.
Results
PKCtheta mRNA expression is selectively induced in LPS/
IFNgamma polarizing conditions
PKCtheta has been reported to regulate the expression
of various genes in T cells [17]. To examine whether
PKCtheta modulates Mφ polarization in pro- or anti-
inflammatory milieu conditions, we analysed mRNA ex-
pression patterns of PKCtheta in bone marrow-derived
macrophages (BMDM) polarized with lipopolysaccharide
(LPS)/interferon-gamma (IFNgamma) or with IL-4, re-
spectively (Fig. 1a). For proper polarization, marker gene
expression of iNOS (for CAM) and Fizz-1 (for AAM)
was monitored (Fig. 1b + c). As a remarkable result,
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Fig. 1 PKCtheta mRNA levels are transiently induced in an LPS/IFNgamma-dependent manner in both mouse and human macrophages: a BMDMs
were differentiated and polarized to CAMs (LPS/IFNgamma) and AAMs (IL-4). PKCtheta gene expression was determined by qRT-PCR after different time
points and was found to be selectively expressed under CAM polarization. Data shown are derived from at least three independent experiments and
qRT-PCR data were normalized to Gapdh. Error bars denote the mean ± s.e.m. *p < 0.05; ** p < 0.01; Expression of unstimulated macrophages was
arbitrarily set to 1. b + c In order to control proper polarization of macrophages, gene expression of prominent markers (iNOS for CAM, Fizz-1 for AAM)
were validated. d CD14+ human monocytes from peripheral blood were differentiated and polarized with LPS/IFNgamma. After predetermined time
periods, gene expression of PKCtheta was analysed with qRT-PCR, revealing an increase in PKCtheta mRNA levels upon stimulation in the human
setting, consistent with results from mouse experiments. Data shown are relative to expression of unstimulated macrophages, which was arbitrarily set
to 1. All data were normalized to Gapdh
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IFNgamma-polarized but not in IL-4-polarized cells. Of
note, PKCtheta mRNA up-regulation in CAMs peaked at
4 h. These results suggest a subset-selective role for
PKCtheta as “signaling intermediate” of pro-inflammatory
Mφ. Reminiscent to mouse cells, PKCtheta is inducibly
expressed in human CD14+ monocytes polarized with
LPS/IFNgamma, indicating a possible role of PKCtheta
also in fine-tuning of the cellular phenotype of human
cells (Fig. 1d).
PKCtheta is causally involved in the protection from
peritoneal S. typhimurium infection
Based on significant PKCtheta expression level in CAMs,
we investigated its potential role in bacterial killing,
employing infection assays with intracellular Gram-
negative S. typhimurium bacteria in vivo and ex vivo.
Evaluation of wild-type and PKCtheta−/− mice during
systemic infection showed that all of the PKCtheta−/− mice
died within 16 days whereas a minimum of 50 % wild-type
mice survived, suggesting a critical role for PKCtheta in
the host defense against S. typhimurium (Fig. 2a). As
PKCtheta−/− mice started to die around day 4–5, we mon-
itored the bacterial load in spleen and liver at day 4 which
revealed a significant increase in the number of colony-
forming units (cfu) of S. typhimurium in PKCtheta−/−
mice (Fig. 2b). These data clearly establish an essential
and non-redundant positive role of PKCtheta in protec-
tion from S. typhimurium.
T cells are not primarily responsible for the reduced
survival of PKCtheta−/− mice after peritoneal infection
with S. typhimurium
To investigate whether T cells contribute to the signifi-
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Fig. 2 PKCtheta−/− mice show markedly decreased survival and increased number of colony-forming units in spleen and liver compared to wild-type mice.
a Survival studies of wild-type (WT) versus PKCtheta−/− mice revealed a significant disadvantage of PKCtheta-deficient animals after intraperitoneal injection
of 50,000 cfu of S. typhimurium depicted by a Kaplan-Meier curve and statistically analysed by the log-rank test (p= 0.0024). b Bacterial loads in spleen and
liver were determined on day 4 after infection with S. typhimurium and displayed a significant increase in cfu in PKCtheta−/− mice. Data are expressed as
mean ± s.e.m. *p< 0.05; c In order to investigate the role of T cells in the survival disadvantage of PKCtheta−/− mice after infection with S. typhimurium, CD4
+ and CD8+ T cells were depleted with the corresponding antibodies prior to infection. IgG isotype antibodies were used for control animals. Results show
no difference in survival in T cell-depleted mice versus mice with IgG control, indicating a negligible role of CD4+ and CD8+ T cells in the reduced survival
rate of PKCtheta−/− mice. Data are expressed as mean ± s.e.m. *p< 0.05; d Depletion of CD4+ and CD8+ T cells was controlled by FACS analysis on day 0
(prior to depletion), day 1 (infection with S. typhimurium) and day 3. Antibodies and IgG controls were injected every third day during the course of
the experiment
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during S. typhimurium infection, we depleted CD4+ and
CD8+ T cells with antibodies before injection of S. typhi-
murium (Fig. 2c). Depletion antibodies were re-injected
every 3 days during the course of the experiment.
Isotype-matched antibodies were injected as depletion
control and effective depletion was controlled by FACS
analysis (Fig. 2d). The results showed no significant
difference in survival of mice injected either with CD4
and CD8 depletion antibodies or isotype control, indicat-
ing that T cells are not primarily responsible for the
reduced survival rate of PKCtheta−/− mice. These data
suggest that PKCtheta−/− mice fail to mount the appro-
priate innate immune responses after infection with S.
typhimurium.
PKCtheta plays a crucial role in repression of IL-10 pro-
duction in vitro and in vivo
In T cells, PKCtheta is known to affect a wide range of
transcription factors such as AP-1, NF-kappaB and
NFAT, regulating i.e. IL-2 activation responses. Add-
itionally, PKCtheta influences the transcription of
miRNA clusters [18] and, in turn, controls expression of
many other genes. To investigate a PKCtheta signaling
function upstream of cytokine responses in Mφ, LPS/
IFNgamma-polarized BMDMs from wild-type and
PKCtheta−/− mice were monitored for pro- and anti-
inflammatory cytokine production at different time
points. Although we could not detect any differences in
the production of IL-6, IL-12p40, TNF-alpha as well as
iNOS expression (data not shown) in polarized
PKCtheta−/− CAMs, we found a significantly increased
production of the anti-inflammatory cytokine IL-10 in
vitro (Fig. 3a). Of, note, the anti-inflammatory cytokine
TGFβ response of polarized PKCtheta−/− CAMs,
remained unchanged both at the protein and the mRNA
levels (Fig. 3b and data not shown), indicating a selectiv-
ity of PKCtheta signaling function. Mechanistically and
albeit our results do not rule out effects of PKCtheta
deficiency on TLR4 signaling responses in general,
PKCtheta does not regulate TLR4 signaling leading to
IRF3 activation response (Fig. 3c). In agreement with
this observation, the significantly lowered survival rates
of PKCtheta−/− mice during peritoneal S. typhimurium
infection correlated with significantly higher IL-10
serum levels (Fig. 3d). Additionally, after injecting LPS
intraperitoneally, the anti-inflammatory IL-10 serum
response in PKCtheta-deficient mice was profoundly
increased after 2 to 24 h (Fig. 3e). This further confirms
the increased IL-10 production by myeloid cells in an-
other in vivo model. Thus, although Mφ from either
PKCtheta−/− or wild-type mice were polarized into
CAMs, only wild-type Mφ but not PKCtheta-deficient
Mφ mounted a functional anti-bacterial activity.
PKCtheta-mediated IL-10 repression affects bacterial kill-
ing of macrophages in vitro
Because containment and killing of S. typhimurium after
invasion of Mφ is a key event in host protection, we moni-
tored intracellular bacterial loads of S. typhimurium-in-
fected Mφ of both genotypes, reproducibly demonstrating
increased bacterial numbers in PKCtheta−/− CAMs as com-
pared to wild-type macrophages (Fig. 4a). In order to inves-
tigate a direct role of IL-10 hyper-production for the
reduced killing capacity of Salmonella-infected PKCtheta−/−
Mφ, IL-10 was neutralized with IL-10 blocking- or isotype
control antibodies. We observed that IL-10 blocking anti-
body treatment rescued the killing capacity of PKCtheta-
deficient cells back to the wild-type level (Fig. 4a). Similar
to genetic PKCtheta depletion, pharmacological PKCtheta
inhibition by the PKC-selective inhibitor AEB071 (Sotras-
taurin) [19] significantly reduced the killing capacity of S.
typhimurium-infected wild-type Mφ (Fig. 4b). Taken
together, these results suggest that PKCtheta is critically
involved in bacterial killing of S. typhimurium-infected Mφ
by suppressing IL-10 production.
Discussion
S. typhimurium is a Gram-negative, motile, facultative
intracellular bacterium, which invades and multiplies
within mononuclear phagocytic cells in liver, spleen,
lymph nodes, and Peyer’s plaques [20, 21]. S. typhimurium
causes severe gastrointestinal disorders in humans and
typhoid fever with systemic infections in mice. Mφ func-
tions have been strongly implicated in infectious diseases.
Mφ, as one of the first barriers of the innate immune sys-
tem, rapidly control S. typhimurium. Importantly, how-
ever, these bacteria may evade immune control and even
multiply within Mφ by mechanisms that are insufficiently
understood so far [22, 23].
The immune response to bacterial infection is regu-
lated by the counter-play between different Mφ subsets,
namely CAMs and AAMs. Changes in the balance of
CAM- and AAM- subsets and their effector cytokines
result in alterations of disease progression. Recognition
of Gram-negative bacteria in Mφ involves the binding of
LPS to TLR4, leading to secretion of key cytokines [24,
25]. Furthermore, Mφ produce ROS by the phagocyte
NADPH oxidase (NOX2; phox) and RNS by the
inducible nitric oxide synthase (iNOS; NOS2) to combat
bacteria. To counteract chronic pro-inflammatory im-
mune effector mechanisms, the production of anti-
inflammatory proteins IL-10 and TGFbeta by Mφ is
induced [26, 27]. NO, generated by IFNgamma-induced
iNOS, is shut down with a shift to Arg1, and YM1 and
YM2 are strongly induced, subsequently leading to the
induction of a Th2 immune response [28].
IL-10 plays an essential part in dampening inflammation
[29]. Consequently, dysregulation of IL-10 is linked with
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susceptibility and an impaired clinical course of numerous
infections in mouse models and in humans [30–32].
Mechanistically, distinct signaling and epigenetic chroma-
tin remodelling of the IL10 locus control the production
of IL-10. Furthermore, post-transcriptional events through
e.g. microRNA represent a critical step for IL-10 transcript
stability.
In response to LPS, TLR4 mediated signaling utilizes
IRF3 to induce an IL-10 transcription response. Never-
theless, a number of additional transcription factors in-
cluding signal transducers and activators of transcription
(STAT), activator protein (AP), cAMP response element
binding protein (CREB), CCATT enhancer/binding pro-
tein (C/EBP), c-musculoaponeurotic fibrosarcoma factor
(c-MAF), and nuclear factor kappa B (NF-kappaB), have
been characterized as essential or critical in myeloid
cell-type-specific IL-10 gene regulation. Thus a compre-
hensive understanding of the detailed cellular pro-
cesses of PKCtheta that contribute in a CAM cell-
specific manner to IL-10 transcriptional regulation
remains elusive. Albeit we cannot define the exact
signaling function of PKCtheta upstream of Il10 tran-
scriptional regulation, the results are in a line with
our observation of increased IL-10 formation in
PKCtheta-deficient BMDMs and that neutralization of
IL-10 results in an improved control of bacterial pro-
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Fig. 3 PKCtheta deficiency leads to IL-10 hyperproduction of bone marrow-derived macrophages. a, b Bioplex technology was used to analyse secretion
responses of the anti-inflammatory cytokines IL-10 (a) and TGFbeta (b) in the supernatant of differentiated and LPS/IFNgamma-polarized macrophages
from PKCtheta−/− versus WT mice. Error bars show the mean of at least three independent experiments ± s.e.m. *p < 0.05; ***p < 0.001; c Differentiated
BMDM were allowed to rest for 1 h in X-Vivo 20 medium and were then stimulated with LPS/IFNgamma (100 ng/ml and 10 ng/ml, respectively) for 2
and 4 h and whole cell lysates were subjected to immunoblotting against phosphorylated IRF3 and total IRF3. d Analysis of IL-10 serum concentration
of WT and PKCtheta−/− mice after infection with S. typhimurium from day 0 to day 4 with Bioplex technology. Error bars show the mean of at least
three independent experiments ± s.e.m. **p < 0.01; e IL-10 serum levels from peripheral blood of wild-type featuring PKCtheta−/− mice after challenging
mice with intraperitoneal LPS injection as an alternative infection model. Data were collected from at least three experiments and shown as mean ±
s.e.m. *p < 0.05; **p < 0.01
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Conclusions
We demonstrate that PKCtheta contributes to a host-
protective immune response against peritoneal S. typhi-
murium infection by its selective involvement during early
(up to 24 h) pro-inflammatory CAM polarization. This
time frame is in agreement with the fact that in these cells
PKCtheta is induced immediately and transiently after
LPS/IFNgamma engagement. PKCtheta deficiency, as
defined in this study, leads to an altered CAM phenotype,
based on an incomplete suppression of the macrophage
deactivating cytokine IL-10. The detailed molecular basis
of PKCtheta-dependent regulation of IL-10 production
under CAM-promoting conditions, and thus the pheno-
typic instability of PKCtheta−/− CAMs, however, remains
unknown. Nevertheless, the data define a previously un-
known regulatory role of PKCtheta in macrophage driven
innate defense mechanisms against bacterial infections. As
an innovative paradigm, CAM-intrinsic PKCtheta may
represent a transiently inducible signaling intermediate
leading to IL-10 suppression, and subsequently, to an
effective anti-bacterial immunity against intracellular bac-
teria such as S. typhimurium. This hypothesis is based on
the increased IL-10 expression observed during the
PKCtheta−/− CAM-priming phase. Of note, this deregu-
lated IL-10 expression level observed in PKCtheta−/−
CAMs is directly responsible for their bacterial killing
defects after infection with S. typhimurium.
In summary, the findings of this study provide genetic
evidence that PKCtheta is an early factor involved in devel-
oping a stable CAM-mediated immune response in vitro
and in vivo. Our results provide first experimental evidence
for an involvement of PKCtheta in Mφ biology, a finding
relevant for the understanding of PKCtheta in innate anti-
microbial immune effector function.
Methods
Mice
Wild-type and PKCtheta−/− mice (on mixed C57BL/
6x129/Sv background) were maintained under specific
pathogen-free conditions in the central animal facility of
the Medical University of Innsbruck. PKCtheta−/− mice
have previously been described in detail (3). All animal
experiments have been performed in accordance with
national and European guidelines and have been
reviewed and authorized by the committee on animal
experiments (Federal Ministry of Science, Research and
Economy-66.0ll/0128-WF/V/3b/2014).
Cell culture
Bone marrow-derived macrophages (BMDM) were har-
vested from tibiae and femora of 8 to 12-week-old mice
and differentiated for 7 days in complete DMEM (Bio-
chrom) supplemented with 10 % FCS, 2 mM L-glutamine,
10,000 U/mL penicillin plus 10 mg/mL streptomycin (all
from Biochrom) and 15 % L929 supernatant. Medium was
replaced after 4 days. On day 7, cells were washed with
phosphate-buffered saline (PBS) and polarized with either
10 ng/ml LPS (L6511; Sigma-Aldrich) and 10 ng/ml
IFNgamma (BMS326, eBioscience) or with 10 ng/ml IL-4
(14-8041-62; eBioscience) for different time periods in X-
Vivo 20 medium (BE04-448Q, Lonza).
Western blotting
BMDM (1 × 106) were lysed in lysis buffer (50 mM Tris–
HCl, pH 7.3, 5 mM NaF, 5 mM Na3VO4, 5 mM NaP2P,
5 mM EDTA, 50 mM NaCl, 1 % NP-40, 50 μg/ml apro-
tinin, 50 μg/ml leupeptin) and subjected to SDS-PAGE
on Bis/Tris-buffered gels (Novex). After transfer to
nitrocellulose membrane by semi-dry blotting, Ser-396
phosphorylated as well as pan-IRF3 were detected by
immune blotting (both with antibodies from Cell
Signaling Technology).
Gene expression analysis
Total RNA was isolated using the RNeasy® Mini Kit
(Qiagen) according to the manufacturer’s instructions.
cDNA was synthesized using the Qiagen Omniscript RT
Kit and oligo(dT) primers (Promega). Expression ana-
lysis was performed with real-time PCR using TaqMan
technology (assays from Applied Biosystem). Reactions



























Fig. 4 PKCθ is involved in bacterial killing of macrophages after infection
with S. typhimurium via inhibition of IL-10 deregulation. a Killing capacity
of BMDMs from WT versus PKCtheta−/− mice was investigated after
infection of macrophages with S. typhimurium. Macrophages were
treated with IL-10 or IgG control antibodies. Significantly enhanced
numbers of colony-forming units (cfu) were found in lysates of
macrophages from PKCtheta−/− mice compared to WT mice. This effect
could be abrogated with IL-10 blockade. Data represent the mean of at
least three independent experiments ± s.e.m. *p< 0.05; b PKC inhibitor
AEB071 enhanced cfu in macrophages infected with S. typhimurium
highly significantly as shown in a killing experiment with BMDM from
WT mice. DMSO served as control vehicle. Error bars denote the
mean ± s.e.m. ***p< 0.001
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Detection System. All gene expressions were normalized
to Gapdh.
Human CD14+ monocyte polarization
Ficoll-Paque Premium (17-5442-02; GE-Life Sciences)
was used to isolate mononuclear cells from blood of
healthy volunteers according to the manufacturer’s
instructions. CD14+ cells were positively selected with
human CD14 MicroBeads (130-050-201; MACS Miltenyi
Biotec) and cultured in DMEM (BioWhittaker BE12-707 F,
Lonza) supplemented with 10 % FCS, 2 mM L-glutamine,
1 % penicillin plus streptomycin (10,000 U/mL penicillin
and 10 mg/mL streptomycin in 0.9 % NaCl), and
100 ng/ml of human GM-CSF (572903, BioLegend).
Cells were fed on day 4 and stimulated with 10 ng/ml
LPS (lipopolysaccharide from S. typhimurium L6511;
Sigma-Aldrich, Vienna, Austria) and 10 ng/ml human
IFNgamma (570204, BioLegend) on day 7 for the indi-
cated time periods.
Bacteria-induced infection model
8 to 12-week-old male WT and PKCtheta−/− mice were
infected intraperitoneally with 50,000 cfu of Salmonella
enterica serovar typhimurium (ATCC14028) diluted in
200 μl PBS, and survival was monitored over 21 days.
For cytokine measurement, blood samples were taken
on day 0 to day 4 and serum was collected. Bacterial
load of organs was determined by plating serial dilutions
of organ homogenates from day 4 after infection on LB
broth agar (L7275-500TAB; Sigma-Aldrich) under sterile
conditions and the number of bacteria was calculated
per gram of tissue after cultivation.
In vivo T cell depletion
Mice were injected with 500 μg of anti-mouse CD4 (clone
GK1.5; BE003-1) and anti-mouse CD8 antibody (clone
YTS 169.4; BE0117), or the corresponding IgG2b (clone
LTF-2; BE0090) control (all from BioXCell, USA) 1 day
prior to infection with S. typhimurium. Facial vein blood
was taken after 24 h to control T cell depletion by FACS
analysis using antiCD4-FITC, antiCD8-APC, and antiCD3-
PE (all from eBioscience). Thereafter, 5,000 to 30,000 cfu S.
typhimurium were injected intraperitoneally. 300 μg of
depletion antibodies or isotype control were administered
every third day throughout the entire experiment.
Cytokine measurements
IL-10 and TGFbeta cytokine levels from from serum or
cell culture supernatants were analyzed with Bio-Plex
multianalyte technology (BioRad).
Endotoxin-induced infection model
WT and PKCtheta−/− mice were treated with intraperito-
neal injection of 15 mg LPS (lipopolysaccharide from S.
typhimurium L6511; Sigma-Aldrich) per kg of body
weight. Serum was collected 4 h after LPS challenge for
analysis of IL-10.
Salmonella infection in vitro
Macrophages were isolated as described above and incu-
bated in complete DMEM without antibiotics. Wild-type
strain S. typhimurium was cultured in LB broth to late-
logarithmic phase. Mφ were infected with S. typhimur-
ium at a multiplicity of infection (MOI) of 10 for 1 h.
Thereafter, cells were washed with PBS and incubated in
complete DMEM containing gentamycin (Gibco). For
killing experiments, prior to infection, cells were treated
with a monoclonal rat anti-mouse IL-10 antibody
(10 μg/ml; clone JES5-2A5; 504903; BioLegend) or the
appropriate isotype control (10 μg/ml; clone RTK2071;
400413; BioLegend) for 23 h. AEB071 (sotrastaurin) was
used as PKC inhibitor in killing experiments and cells
were treated with 1 μM for 23 h. After infection, intra-
cellular bacterial loads were harvested with 0.5 % sodium
deoxycholic acid (D6750; Sigma-Aldrich) as described
previously [33].
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